Oxford Global’s 4th Annual Cell & Gene Therapy Congress will bring together over 400 senior level experts from pharmaceutical and biotechnology companies will meet to discuss the most recent developments and key challenges within the industry.
Oxford Global is proud to present the 4th Annual Cell & Gene Therapy Congress to be held on the 25-26 of October 2018 in London, UK. Together with our prestigious collocated 7th Annual Cell Culture & Bioprocessing Congress, 5th Annual Stem Cell Congress & Regenerative Medicine Congress and Biobanking Congress, over 400 senior level experts from pharmaceutical and biotechnology companies will meet to discuss the most recent developments and key challenges within the industry.
3 interactive streams:
- Day 1 Stream 1: Cell & Gene Therapy Development & Clinical Trials
- Day 1 Stream 2: Cell & Gene Therapy Bioprocessing & Manufacturing Strategies
- Day 2 Stream 1: Commercialising Cell & Gene Therapy Treatments
Day 1, Stream 1 will concentrate on the development of cell and gene therapy and clinical trials, Including the most recent advances in cell-based therapies, novel vector systems, and the future of cell & gene therapy development. We will have a Stream 2 focusing on bioprocessing and manufacturing strategies for Cell & Gene Therapy. Big challenges such as manufacturing standardisation, product characterisation, and eventual commercialisation will be addressed, as well as ensuring product efficacy, automation and the scaling up/out of manufacturing.
Our Day 2 stream explores the commercialization Cell & Gene Therapy treatments, with regulatory perspectives, challenges pertaining to the development and approval of novel cell and gene therapies, collaboration between industry and academic institutions, and reimbursement and pricing strategies.
For further information on the congress and to receive prices and booking details, please contact Guillaume Alonso at [email protected] or call +44 (0)1865 248 455